Literature DB >> 24088286

Critique of re-analysis of the TROPHY study.

Jay I Meltzer1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24088286      PMCID： PMC8033900          DOI： 10.1111/jch.12149

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  5 in total

1.  A specialist in clinical hypertension critiques the TROPHY trial.

Authors:  Jay I Meltzer
Journal:  Am J Hypertens       Date:  2006-11       Impact factor: 2.689

2.  Feasibility of treating prehypertension with an angiotensin-receptor blocker.

Authors:  Stevo Julius; Shawna D Nesbitt; Brent M Egan; Michael A Weber; Eric L Michelson; Niko Kaciroti; Henry R Black; Richard H Grimm; Franz H Messerli; Suzanne Oparil; M Anthony Schork
Journal:  N Engl J Med       Date:  2006-03-14       Impact factor: 91.245

3.  Trial of preventing hypertension: design and 2-year progress report.

Authors:  Stevo Julius; Shawna Nesbitt; Brent Egan; Niko Kaciroti; M Anthony Schork; Melissa Grozinski; Eric Michelson
Journal:  Hypertension       Date:  2004-07-06       Impact factor: 10.190

4.  Visit-to-visit blood pressure variation--time to re-analyze all the data from the Trial of Preventing Hypertension (TROPHY) study.

Authors:  Johan M van Schalkwyk; Martin J Turner
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-02-01       Impact factor: 3.738

5.  Reply to Visit-to-visit blood pressure variation: time to reanalyze all the data from the TROPHY study.

Authors:  Stevo Julius; Niko Kaciroti; Suzanne Oparil
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-02-01       Impact factor: 3.738
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.